SILVERLON® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts ...

3. The study demonstrated a 46 percent reduction in the CLABSI rate per 1,000 days in the Silverlon group. 4. Tampa General Hospital has maintained the reduced CLABSI rates since the study period ...

Silverlon has been included in numerous studies that have clearly demonstrated silver nylon dressings can offer advantages that help to improve patient care. Argentum Medical continues to explore new ...

Patients received either CHGIS dressings (Jan.- Dec. 2009) or silver dressings (Jan.- Dec. 2010). Primary outcomes measured were CLABSI rates per 1,000 catheter days and ICU length of stay.

GENEVA, Ill., Aug. 13, 2019 /PRNewswire-PRWeb/ -- Recent lab findings demonstrate that Silverlon® antimicrobial dressings effectively kill Candida Auris (C. Auris), the emerging "superbug ...

GENEVA, Ill.--(BUSINESS WIRE)--Argentum Medical, LLC is very pleased to announce the results of the second reexamination of its US 7,230,153 C1 patent for Silverlon® antimicrobial wound, burn and ...

Argentum Medical, LLC, has received FDA clearances for multiple indications for Silverlon since 2003 and in that time the wound dressing has been used extensively by the U.S. military to treat burn ...

Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure ...

Human clinical trials for the product's use on radiation injuries began in 2018, earning it FDA Breakthrough Device Designation for burn dressings in 2021 and Silverlon's second 510 (k) clearance ...

GENEVA, Ill., Sept. 4, 2018 /PRNewswire-PRWeb/ -- Argentum Medical, maker of Silverlon® antimicrobial dressings, announced today that Amanda Budak, RN, CBN, PhD, will serve as Clinical Director. Dr.